EP Edge Journal Watch — November 2025, Edition 2: From Lifestyle to Lifeline - EP Edge Journal Watch: Cardiac Electrophysiology Research

Om avsnittet

In this episode, Dr. Niraj Sharma breaks down six pivotal studies shaping today’s electrophysiology and cardiology practice—from lifestyle-driven AF control (ARREST-AF) and post-CABG atrial fibrillation management to the DOAC + aspirin conundrum in stable CAD, the return of digitoxin in HFrEF, insights from CABANA-Substudy, and the latest ICD registry data on shock rates.

EP Edge Journal Watch — November 2025, Edition 2: From Lifestyle to Lifeline

Om avsnittet

Fler avsnitt

EP Edge® Journal Watch 37: LAAO vs DOACs, PFA Stroke Risk, Wearable AF Monitoring, PVC Localization, and SGLT2 Sudden Death

EP Edge® Journal Watch 36: ESC 2026, AF Ablation and Sham Trials | PVI-SHAM-AF, PFA-SHAM, SHAM-PVI, FlexPulse, NEXAF, IDEAL-AF, ENRICH-AF

EP Edge® Journal Watch Issue 35: ESC 2026 Munich Special Edition | SINGLE-AF, CMR GUIDE, New HF Guidelines & Fifth Universal Definition of MI

EP Edge® × HRS: Rethinking the Defaults: AFib Ablation vs Antiarrhythmics, Flecainide Beyond CAST, and Physiologic Pacing

EP Edge® Journal Watch Issue 34 August 2026: ICD Shocks, Troponin, PFA Safety, LOSE-AF Weight Loss and POTS, Radiation Expose in the EP Lab

EP Edge® Journal Watch Issue 33, August 2026: Anticoagulation After AF Ablation, PFA Safety, Lead Extraction and Sudden Death Risk

EP Edge® Journal Watch Issue 32 August 2026: AF Ablation Anticoagulation, Flecainide After CAST, AI-ECG & PFA Mapping

EP Edge® Journal Watch Issue 31, August 2026: Caffeine, Wine, Atrial Fibrillation, Pulsed-Field Ablation and Sudden Cardiac Death

EP Edge® Journal Watch Issue 30: VISION AF, Pulsed Field Ablation Safety, PACE-HF and Conduction System Pacing | July 2026

EP Edge® Journal Watch Issue 29: Atrial Fibrillation Ablation vs Antiarrhythmic Drugs, CABANA Progression and Anticoagulation | July 2026